Gao, Jianjun
Ward, John F
Pettaway, Curtis A
Shi, Lewis Z
Subudhi, Sumit K
Vence, Luis M
Zhao, Hao
Chen, Jianfeng
Chen, Hong
Efstathiou, Eleni
Troncoso, Patricia
Allison, James P
Logothetis, Christopher J
Wistuba, Ignacio I
Sepulveda, Manuel A
Sun, Jingjing
Wargo, Jennifer
Blando, Jorge
Sharma, Padmanee
Article History
Received: 16 December 2016
Accepted: 17 February 2017
First Online: 27 March 2017
Competing interests
: P.S. and J.P.A. are founders and advisors for Jounce Therapeutics. P.S. and J.P.A. are members of the Parker Institute for Cancer Immunotherapy. P.S. also serves as a consultant for BMS, AstraZeneca, Amgen, and GlaxoSmithKline. J.P.A. is an inventor of intellectual property owned by the University of California, Berkeley, and licensed to BMS and has received royalties from BMS. J.P.A. is also inventor of intellectual property owned by Memorial Sloan Kettering Cancer Center and licensed to Merck. J.G. serves as a consultant for Genentech. I.I.W. serves as a consultant for BMS. E.E. serves as a consultant for Janssen, Bayer, Medivation, Astellas, and Sanofi Takeda.